|
Market Cap (3-Jul) $23,106,150 (942nd) |
Close (13-Jun) $0.009 |
Volume (13-Jun) 0 |
Shortsold (8-Jun) 1,624,075 (0.07%) (501st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
CPH released this announcement to the ASX on 31 January 2022, 10:05. The announcement is marked as price sensitive, and is 14 page(s) in length and 364.09kb in size.
You can view all announcements from CPH and see how they appear on a price chart on the announcements page.
At the date of this announcement, CPH was 0.830% short sold according to ASIC data. It was ranked the 202nd most shorted stock on the ASX. It remains ranked 501st as of the latest reported data (08 June 2023).
| Other Recent Announcements from CPH | |
|---|---|
| Notification regarding unquoted securities - CPH | 9 June 2023, 16:23 |
| LOI to Import MDMA & Psilocybin Treatments to Australia | 9 June 2023, 9:42 |
| Application for quotation of securities - CPH | 8 June 2023, 18:23 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 31 January 2022, 10:05 |
| Application for quotation of securities - CPH | 28 January 2022, 20:08 |
| Application for quotation of securities - CPH | 28 January 2022, 19:56 |
| Halucenex Lodges Clinical Trial Authorisation | 25 January 2022, 10:58 |
You must be logged in to post a reply.
Creso Pharma 